SRS advises Bionova Capital on investment in Vaxydn

SRS advogados has advised Bionova Capital on its investment in the Spanish startup, Vaxydn, to develop a vaccine against fatal bacteria

pjimage 22SRS Advogados has advised Bionova Capital (ex-Hovione Capital) on its investment in Vaxdyn, a startup company based in Spain and operating in the area of biotechnology. The investment is to fund the development of vaccines against potentially fatal bacteria.

In this funding round, Vaxdyn raised €7.6 million from various investors, with the aim of developing a new vaccine to combat the global crisis of superbugs, namely those that cause pneumonia. Bionova Capital is a leading investor in life sciences and biomedical start-ups in the Portuguese market, investing in molecules and medical devices.

The team from SRS Advogados was led by partner Paulo Bandeira (pictured left) and associate Giorgio Galli (pictured right).

“This advisory service stands out due to the complexity of combining different financing instruments in the transaction and the need to acculturate the practice of venture capital investment by Portuguese investors to investment and governance models in other jurisdictions”, emphasises Paulo Bandeira, partner responsible for the Startup Lab at SRS.


SRS advises Bionova Capital on investment in Vaxydn

Michael Heron

Iberian Lawyer, is a monthly digital magazine, published by LC Publishing, available in Spanish and English. It represents the main source of information in the legal business sector in Spain and Portugal. The digital magazine – and its portal – address to the protagonists of law firms and in-house lawyers. The magazine is available for free on the website and on Google Play and App Store.

In every issue of the magazine, you will find rankings of lawyers, special report on trends, interviews, information about deals and their advisors.

For further information, please visit the Group’s website

Iberian Legal Group, S.L.
Registered office: C/ Ríos Rosas 44A - 2 G,H 28003 Madrid España

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram